The inhibitory effect of a drug combination on the development of mefloquine resistance in<i>Plasmodium berghei</i>

B. Merkli, R. Richle, W. Peters

Annals of Tropical Medicine and Parasitology · 1980 · 53 citations · 19 references

Concepts

Abstract

Lines of Plasmodium berghei were exposed to drug selection pressure in successive passages in mice. The compounds used were chloroquine, mefloquine, a 2:1 mixture of sulphadoxine with pyrimethamine (S-P), and a variable mixture of mefloquine with S-P. Resistance developed to all lines. Resistance to the S-P combination developed significantly more slowly than did resistance to chloroquine or mefloquine. The development of resistance to the mixture of mefloquine and S-P was greatly inhibited.The joint blood schizontocidal action of mefloquine with the S-P combination was shown to be additive, not potentiating.Resistance to all the compounds used under these experimental conditions was shown to be unstable on withdrawal of the drug selection pressure.The mefloquine-resistant line remained sensitive to chloroquine but was cross-resistant to quinine and to a synthetic quinine analogue. The line which was resistant (at a low level) to mefloquine plus S-P was sensitive to chloroquine, but was resistant to pyrimethamine or sulphadoxine if these were used alone, and even, to a lesser degree, to the S-P combination.The significance of these observations is discussed in relation to drug resistance in P. falciparum. It is considered that mefloquine resistance is a possibility against which precautions should be taken, and a rationale is developed for the field trial of a mixture of mefloquine plus a combination of sulphadoxine with pyrimethamine (Fansidar ®).

References

19